In a recent meta-analysis study, increased plasma resistin level has been linked to an enhanced incidence of obesity-related cancers, such as breast, endometrial, and colorectal cancer, although resistin level cannot be considered a predictor factor [98]. Here, RETN is linked to obesity disorder.